Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus.
Identifieur interne : 000066 ( Hal/Curation ); précédent : 000065; suivant : 000067Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus.
Auteurs : Gary P. Kobinger [Canada] ; Isabelle Meunier [Canada] ; Ami Patel [Canada] ; Stéphane Pillet [Canada] ; Jason Gren [Canada] ; Shane Stebner [Canada] ; Anders Leung [Canada] ; James L. Neufeld [Canada] ; Darwyn Kobasa [Canada] ; Veronika Von Messling [Canada]Source :
- Journal of Infectious Diseases [ 0022-1899 ] ; 2010-04-01.
Abstract
BACKGROUND: The emergence and global spread of the pandemic H1N1 2009 influenza virus have raised questions regarding the protective effect of available seasonal vaccines and the efficacy of a newly produced matched vaccine. METHODS: Ferrets were immunized with the 2008-2009 formulations of commercially available live attenuated (FluMist; MedImmune) or split-inactivated (Fluviral; GlaxoSmithKline) vaccines, a commercial swine vaccine (FluSure; Pfizer), or a laboratory-produced matched inactivated whole-virus vaccine (A/Mexico/InDRE4487/2009). Adaptive immune responses were monitored, and the animals were challenged with A/Mexico/InDRE4487/2009 after 5 weeks. RESULTS: Only animals that received the swine or matched vaccines developed detectable hemagglutination-inhibiting antibodies against the challenge virus, whereas a T cell response was exclusively detected in animals vaccinated with FluMist. After challenge, all animals had high levels of virus replication in the upper respiratory tract. However, preexisting anti-pandemic H1N1 2009 antibodies resulted in reduced clinical signs and improved survival. Surprisingly, FluMist was associated with a slight increase in mortality and greater lung damage, which correlated with early up-regulation of interleukin-10. CONCLUSIONS: The present study demonstrates that a single dose of matched inactivated vaccine confers partial protection against a pandemic H1N1 2009 virus, and it suggests that a higher dose or prime-boost regimen may be required. The consequences of mismatched immunity to influenza merit further investigation.
Url:
DOI: 10.1086/651171
Links toward previous steps (curation, corpus...)
- to stream Hal, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000066
Links to Exploration step
Hal:pasteur-00819560Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus.</title>
<author><name sortKey="Kobinger, Gary P" sort="Kobinger, Gary P" uniqKey="Kobinger G" first="Gary P" last="Kobinger">Gary P. Kobinger</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-224470" status="INCOMING"> <orgName>Department of Medical Microbiology</orgName>
<desc> <address> <addrLine>Winnipeg, Manitoba</addrLine>
<country key="CA"></country>
</address>
</desc>
<listRelation> <relation active="#struct-300724" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-300724" type="direct"><org type="institution" xml:id="struct-300724" status="VALID"> <orgName>University of Manitoba [Winnipeg]</orgName>
<date type="start">2017-04-10</date>
<desc> <address> <addrLine>Winnipeg, Manitoba Canada R3T 2N2</addrLine>
<country key="CA"></country>
</address>
<ref type="url">http://umanitoba.ca/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Meunier, Isabelle" sort="Meunier, Isabelle" uniqKey="Meunier I" first="Isabelle" last="Meunier">Isabelle Meunier</name>
<affiliation wicri:level="1"><hal:affiliation type="regrouplaboratory" xml:id="struct-54664" status="VALID"> <orgName>Institut Armand Frappier</orgName>
<orgName type="acronym">INRS-IAF</orgName>
<desc> <address> <addrLine>531 boul. des Prairies Laval (Québec) H7V 1B7</addrLine>
<country key="CA"></country>
</address>
<ref type="url">http://www.iaf.inrs.ca</ref>
</desc>
<listRelation> <relation active="#struct-301247" type="direct"></relation>
<relation active="#struct-92448" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-301247" type="direct"><org type="regroupinstitution" xml:id="struct-301247" status="VALID"> <orgName>Réseau International des Instituts Pasteur</orgName>
<orgName type="acronym">RIIP</orgName>
<desc> <address> <addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://research.pasteur.fr/ip-network</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-92448" type="direct"><org type="institution" xml:id="struct-92448" status="VALID"> <orgName>Institut National de la Recherche Scientifique [Québec]</orgName>
<orgName type="acronym">INRS</orgName>
<desc> <address> <addrLine>490 rue de la Couronne, Québec, QC G1K 9A9</addrLine>
<country key="CA"></country>
</address>
<ref type="url">http://www.inrs.ca/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Patel, Ami" sort="Patel, Ami" uniqKey="Patel A" first="Ami" last="Patel">Ami Patel</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-224469" status="INCOMING"> <orgName>Special Pathogens Programme, National Microbiology Laboratory</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
<listRelation> <relation active="#struct-308348" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-308348" type="direct"><org type="institution" xml:id="struct-308348" status="INCOMING"> <orgName>Public Health Agency of Canada</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Pillet, Stephane" sort="Pillet, Stephane" uniqKey="Pillet S" first="Stéphane" last="Pillet">Stéphane Pillet</name>
<affiliation wicri:level="1"><hal:affiliation type="regrouplaboratory" xml:id="struct-54664" status="VALID"> <orgName>Institut Armand Frappier</orgName>
<orgName type="acronym">INRS-IAF</orgName>
<desc> <address> <addrLine>531 boul. des Prairies Laval (Québec) H7V 1B7</addrLine>
<country key="CA"></country>
</address>
<ref type="url">http://www.iaf.inrs.ca</ref>
</desc>
<listRelation> <relation active="#struct-301247" type="direct"></relation>
<relation active="#struct-92448" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-301247" type="direct"><org type="regroupinstitution" xml:id="struct-301247" status="VALID"> <orgName>Réseau International des Instituts Pasteur</orgName>
<orgName type="acronym">RIIP</orgName>
<desc> <address> <addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://research.pasteur.fr/ip-network</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-92448" type="direct"><org type="institution" xml:id="struct-92448" status="VALID"> <orgName>Institut National de la Recherche Scientifique [Québec]</orgName>
<orgName type="acronym">INRS</orgName>
<desc> <address> <addrLine>490 rue de la Couronne, Québec, QC G1K 9A9</addrLine>
<country key="CA"></country>
</address>
<ref type="url">http://www.inrs.ca/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Gren, Jason" sort="Gren, Jason" uniqKey="Gren J" first="Jason" last="Gren">Jason Gren</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-224469" status="INCOMING"> <orgName>Special Pathogens Programme, National Microbiology Laboratory</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
<listRelation> <relation active="#struct-308348" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-308348" type="direct"><org type="institution" xml:id="struct-308348" status="INCOMING"> <orgName>Public Health Agency of Canada</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Stebner, Shane" sort="Stebner, Shane" uniqKey="Stebner S" first="Shane" last="Stebner">Shane Stebner</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-224469" status="INCOMING"> <orgName>Special Pathogens Programme, National Microbiology Laboratory</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
<listRelation> <relation active="#struct-308348" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-308348" type="direct"><org type="institution" xml:id="struct-308348" status="INCOMING"> <orgName>Public Health Agency of Canada</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Leung, Anders" sort="Leung, Anders" uniqKey="Leung A" first="Anders" last="Leung">Anders Leung</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-224469" status="INCOMING"> <orgName>Special Pathogens Programme, National Microbiology Laboratory</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
<listRelation> <relation active="#struct-308348" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-308348" type="direct"><org type="institution" xml:id="struct-308348" status="INCOMING"> <orgName>Public Health Agency of Canada</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Neufeld, James L" sort="Neufeld, James L" uniqKey="Neufeld J" first="James L" last="Neufeld">James L. Neufeld</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-224471" status="INCOMING"> <orgName>Canadian Food Inspection Agency</orgName>
<desc> <address> <addrLine>Winnipeg, Manitoba</addrLine>
<country key="CA"></country>
</address>
</desc>
<listRelation> <relation active="#struct-354485" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-354485" type="direct"><org type="institution" xml:id="struct-354485" status="INCOMING"> <orgName>National Centre for Foreign Animal Disease</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Kobasa, Darwyn" sort="Kobasa, Darwyn" uniqKey="Kobasa D" first="Darwyn" last="Kobasa">Darwyn Kobasa</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-224469" status="INCOMING"> <orgName>Special Pathogens Programme, National Microbiology Laboratory</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
<listRelation> <relation active="#struct-308348" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-308348" type="direct"><org type="institution" xml:id="struct-308348" status="INCOMING"> <orgName>Public Health Agency of Canada</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Von Messling, Veronika" sort="Von Messling, Veronika" uniqKey="Von Messling V" first="Veronika" last="Von Messling">Veronika Von Messling</name>
<affiliation wicri:level="1"><hal:affiliation type="regrouplaboratory" xml:id="struct-54664" status="VALID"> <orgName>Institut Armand Frappier</orgName>
<orgName type="acronym">INRS-IAF</orgName>
<desc> <address> <addrLine>531 boul. des Prairies Laval (Québec) H7V 1B7</addrLine>
<country key="CA"></country>
</address>
<ref type="url">http://www.iaf.inrs.ca</ref>
</desc>
<listRelation> <relation active="#struct-301247" type="direct"></relation>
<relation active="#struct-92448" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-301247" type="direct"><org type="regroupinstitution" xml:id="struct-301247" status="VALID"> <orgName>Réseau International des Instituts Pasteur</orgName>
<orgName type="acronym">RIIP</orgName>
<desc> <address> <addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://research.pasteur.fr/ip-network</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-92448" type="direct"><org type="institution" xml:id="struct-92448" status="VALID"> <orgName>Institut National de la Recherche Scientifique [Québec]</orgName>
<orgName type="acronym">INRS</orgName>
<desc> <address> <addrLine>490 rue de la Couronne, Québec, QC G1K 9A9</addrLine>
<country key="CA"></country>
</address>
<ref type="url">http://www.inrs.ca/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:pasteur-00819560</idno>
<idno type="halId">pasteur-00819560</idno>
<idno type="halUri">https://hal-riip.archives-ouvertes.fr/pasteur-00819560</idno>
<idno type="url">https://hal-riip.archives-ouvertes.fr/pasteur-00819560</idno>
<idno type="doi">10.1086/651171</idno>
<date when="2010-04-01">2010-04-01</date>
<idno type="wicri:Area/Hal/Corpus">000066</idno>
<idno type="wicri:Area/Hal/Curation">000066</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus.</title>
<author><name sortKey="Kobinger, Gary P" sort="Kobinger, Gary P" uniqKey="Kobinger G" first="Gary P" last="Kobinger">Gary P. Kobinger</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-224470" status="INCOMING"> <orgName>Department of Medical Microbiology</orgName>
<desc> <address> <addrLine>Winnipeg, Manitoba</addrLine>
<country key="CA"></country>
</address>
</desc>
<listRelation> <relation active="#struct-300724" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-300724" type="direct"><org type="institution" xml:id="struct-300724" status="VALID"> <orgName>University of Manitoba [Winnipeg]</orgName>
<date type="start">2017-04-10</date>
<desc> <address> <addrLine>Winnipeg, Manitoba Canada R3T 2N2</addrLine>
<country key="CA"></country>
</address>
<ref type="url">http://umanitoba.ca/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Meunier, Isabelle" sort="Meunier, Isabelle" uniqKey="Meunier I" first="Isabelle" last="Meunier">Isabelle Meunier</name>
<affiliation wicri:level="1"><hal:affiliation type="regrouplaboratory" xml:id="struct-54664" status="VALID"> <orgName>Institut Armand Frappier</orgName>
<orgName type="acronym">INRS-IAF</orgName>
<desc> <address> <addrLine>531 boul. des Prairies Laval (Québec) H7V 1B7</addrLine>
<country key="CA"></country>
</address>
<ref type="url">http://www.iaf.inrs.ca</ref>
</desc>
<listRelation> <relation active="#struct-301247" type="direct"></relation>
<relation active="#struct-92448" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-301247" type="direct"><org type="regroupinstitution" xml:id="struct-301247" status="VALID"> <orgName>Réseau International des Instituts Pasteur</orgName>
<orgName type="acronym">RIIP</orgName>
<desc> <address> <addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://research.pasteur.fr/ip-network</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-92448" type="direct"><org type="institution" xml:id="struct-92448" status="VALID"> <orgName>Institut National de la Recherche Scientifique [Québec]</orgName>
<orgName type="acronym">INRS</orgName>
<desc> <address> <addrLine>490 rue de la Couronne, Québec, QC G1K 9A9</addrLine>
<country key="CA"></country>
</address>
<ref type="url">http://www.inrs.ca/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Patel, Ami" sort="Patel, Ami" uniqKey="Patel A" first="Ami" last="Patel">Ami Patel</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-224469" status="INCOMING"> <orgName>Special Pathogens Programme, National Microbiology Laboratory</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
<listRelation> <relation active="#struct-308348" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-308348" type="direct"><org type="institution" xml:id="struct-308348" status="INCOMING"> <orgName>Public Health Agency of Canada</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Pillet, Stephane" sort="Pillet, Stephane" uniqKey="Pillet S" first="Stéphane" last="Pillet">Stéphane Pillet</name>
<affiliation wicri:level="1"><hal:affiliation type="regrouplaboratory" xml:id="struct-54664" status="VALID"> <orgName>Institut Armand Frappier</orgName>
<orgName type="acronym">INRS-IAF</orgName>
<desc> <address> <addrLine>531 boul. des Prairies Laval (Québec) H7V 1B7</addrLine>
<country key="CA"></country>
</address>
<ref type="url">http://www.iaf.inrs.ca</ref>
</desc>
<listRelation> <relation active="#struct-301247" type="direct"></relation>
<relation active="#struct-92448" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-301247" type="direct"><org type="regroupinstitution" xml:id="struct-301247" status="VALID"> <orgName>Réseau International des Instituts Pasteur</orgName>
<orgName type="acronym">RIIP</orgName>
<desc> <address> <addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://research.pasteur.fr/ip-network</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-92448" type="direct"><org type="institution" xml:id="struct-92448" status="VALID"> <orgName>Institut National de la Recherche Scientifique [Québec]</orgName>
<orgName type="acronym">INRS</orgName>
<desc> <address> <addrLine>490 rue de la Couronne, Québec, QC G1K 9A9</addrLine>
<country key="CA"></country>
</address>
<ref type="url">http://www.inrs.ca/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Gren, Jason" sort="Gren, Jason" uniqKey="Gren J" first="Jason" last="Gren">Jason Gren</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-224469" status="INCOMING"> <orgName>Special Pathogens Programme, National Microbiology Laboratory</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
<listRelation> <relation active="#struct-308348" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-308348" type="direct"><org type="institution" xml:id="struct-308348" status="INCOMING"> <orgName>Public Health Agency of Canada</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Stebner, Shane" sort="Stebner, Shane" uniqKey="Stebner S" first="Shane" last="Stebner">Shane Stebner</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-224469" status="INCOMING"> <orgName>Special Pathogens Programme, National Microbiology Laboratory</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
<listRelation> <relation active="#struct-308348" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-308348" type="direct"><org type="institution" xml:id="struct-308348" status="INCOMING"> <orgName>Public Health Agency of Canada</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Leung, Anders" sort="Leung, Anders" uniqKey="Leung A" first="Anders" last="Leung">Anders Leung</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-224469" status="INCOMING"> <orgName>Special Pathogens Programme, National Microbiology Laboratory</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
<listRelation> <relation active="#struct-308348" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-308348" type="direct"><org type="institution" xml:id="struct-308348" status="INCOMING"> <orgName>Public Health Agency of Canada</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Neufeld, James L" sort="Neufeld, James L" uniqKey="Neufeld J" first="James L" last="Neufeld">James L. Neufeld</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-224471" status="INCOMING"> <orgName>Canadian Food Inspection Agency</orgName>
<desc> <address> <addrLine>Winnipeg, Manitoba</addrLine>
<country key="CA"></country>
</address>
</desc>
<listRelation> <relation active="#struct-354485" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-354485" type="direct"><org type="institution" xml:id="struct-354485" status="INCOMING"> <orgName>National Centre for Foreign Animal Disease</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Kobasa, Darwyn" sort="Kobasa, Darwyn" uniqKey="Kobasa D" first="Darwyn" last="Kobasa">Darwyn Kobasa</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-224469" status="INCOMING"> <orgName>Special Pathogens Programme, National Microbiology Laboratory</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
<listRelation> <relation active="#struct-308348" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-308348" type="direct"><org type="institution" xml:id="struct-308348" status="INCOMING"> <orgName>Public Health Agency of Canada</orgName>
<desc> <address> <country key="CA"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Von Messling, Veronika" sort="Von Messling, Veronika" uniqKey="Von Messling V" first="Veronika" last="Von Messling">Veronika Von Messling</name>
<affiliation wicri:level="1"><hal:affiliation type="regrouplaboratory" xml:id="struct-54664" status="VALID"> <orgName>Institut Armand Frappier</orgName>
<orgName type="acronym">INRS-IAF</orgName>
<desc> <address> <addrLine>531 boul. des Prairies Laval (Québec) H7V 1B7</addrLine>
<country key="CA"></country>
</address>
<ref type="url">http://www.iaf.inrs.ca</ref>
</desc>
<listRelation> <relation active="#struct-301247" type="direct"></relation>
<relation active="#struct-92448" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-301247" type="direct"><org type="regroupinstitution" xml:id="struct-301247" status="VALID"> <orgName>Réseau International des Instituts Pasteur</orgName>
<orgName type="acronym">RIIP</orgName>
<desc> <address> <addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://research.pasteur.fr/ip-network</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-92448" type="direct"><org type="institution" xml:id="struct-92448" status="VALID"> <orgName>Institut National de la Recherche Scientifique [Québec]</orgName>
<orgName type="acronym">INRS</orgName>
<desc> <address> <addrLine>490 rue de la Couronne, Québec, QC G1K 9A9</addrLine>
<country key="CA"></country>
</address>
<ref type="url">http://www.inrs.ca/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Canada</country>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.1086/651171</idno>
<series><title level="j">Journal of Infectious Diseases</title>
<idno type="ISSN">0022-1899</idno>
<imprint><date type="datePub">2010-04-01</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"> <p>BACKGROUND: The emergence and global spread of the pandemic H1N1 2009 influenza virus have raised questions regarding the protective effect of available seasonal vaccines and the efficacy of a newly produced matched vaccine. METHODS: Ferrets were immunized with the 2008-2009 formulations of commercially available live attenuated (FluMist; MedImmune) or split-inactivated (Fluviral; GlaxoSmithKline) vaccines, a commercial swine vaccine (FluSure; Pfizer), or a laboratory-produced matched inactivated whole-virus vaccine (A/Mexico/InDRE4487/2009). Adaptive immune responses were monitored, and the animals were challenged with A/Mexico/InDRE4487/2009 after 5 weeks. RESULTS: Only animals that received the swine or matched vaccines developed detectable hemagglutination-inhibiting antibodies against the challenge virus, whereas a T cell response was exclusively detected in animals vaccinated with FluMist. After challenge, all animals had high levels of virus replication in the upper respiratory tract. However, preexisting anti-pandemic H1N1 2009 antibodies resulted in reduced clinical signs and improved survival. Surprisingly, FluMist was associated with a slight increase in mortality and greater lung damage, which correlated with early up-regulation of interleukin-10. CONCLUSIONS: The present study demonstrates that a single dose of matched inactivated vaccine confers partial protection against a pandemic H1N1 2009 virus, and it suggests that a higher dose or prime-boost regimen may be required. The consequences of mismatched immunity to influenza merit further investigation.</p>
</div>
</front>
</TEI>
<hal api="V3"> <titleStmt> <title xml:lang="en">Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus.</title>
<author role="crp"> <persName> <forename type="first">Gary P</forename>
<surname>Kobinger</surname>
</persName>
<email type="md5">873e77335b5b1ffbd6dc15959e65d00c</email>
<email type="domain">phac-aspc.gc.ca</email>
<idno type="halauthorid">859639</idno>
<affiliation ref="#struct-224470"></affiliation>
<affiliation ref="#struct-224469"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Isabelle</forename>
<surname>Meunier</surname>
</persName>
<idno type="halauthorid">683563</idno>
<affiliation ref="#struct-54664"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Ami</forename>
<surname>Patel</surname>
</persName>
<idno type="halauthorid">846029</idno>
<affiliation ref="#struct-224469"></affiliation>
<affiliation ref="#struct-224470"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Stéphane</forename>
<surname>Pillet</surname>
</persName>
<idno type="halauthorid">752167</idno>
<affiliation ref="#struct-54664"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Jason</forename>
<surname>Gren</surname>
</persName>
<idno type="halauthorid">846030</idno>
<affiliation ref="#struct-224469"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Shane</forename>
<surname>Stebner</surname>
</persName>
<idno type="halauthorid">846031</idno>
<affiliation ref="#struct-224469"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Anders</forename>
<surname>Leung</surname>
</persName>
<idno type="halauthorid">846032</idno>
<affiliation ref="#struct-224469"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">James L</forename>
<surname>Neufeld</surname>
</persName>
<idno type="halauthorid">846033</idno>
<affiliation ref="#struct-224471"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Darwyn</forename>
<surname>Kobasa</surname>
</persName>
<idno type="halauthorid">752168</idno>
<affiliation ref="#struct-224469"></affiliation>
<affiliation ref="#struct-200544"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Veronika</forename>
<surname>Von Messling</surname>
</persName>
<idno type="halauthorid">752172</idno>
<affiliation ref="#struct-54664"></affiliation>
</author>
<editor role="depositor"> <persName> <forename>Charles M.</forename>
<surname>Dozois</surname>
</persName>
<email type="md5">629523f1b9cb7933402273e36dd8cc97</email>
<email type="domain">adm.inrs.ca</email>
</editor>
<funder>Financial support: Public Health Agency of Canada; Canadian Institutes forHealth Research (team grant 310641 to D.K., V.v.M., and G.P.K.); Fonds de la Recherche en Santé du Québec (postdoctoral fellowship to S.P.); and Armand-Frappier Foundation (scholarship to I.M.)</funder>
</titleStmt>
<editionStmt> <edition n="v1" type="current"> <date type="whenSubmitted">2013-05-01 21:40:26</date>
<date type="whenModified">2018-10-08 17:44:04</date>
<date type="whenReleased">2013-06-12 13:34:10</date>
<date type="whenProduced">2010-04-01</date>
<ref type="externalLink" target="https://academic.oup.com/jid/article-pdf/201/7/1000/18060930/201-7-1000.pdf"></ref>
</edition>
<respStmt> <resp>contributor</resp>
<name key="174448"> <persName> <forename>Charles M.</forename>
<surname>Dozois</surname>
</persName>
<email type="md5">629523f1b9cb7933402273e36dd8cc97</email>
<email type="domain">adm.inrs.ca</email>
</name>
</respStmt>
</editionStmt>
<publicationStmt> <distributor>CCSD</distributor>
<idno type="halId">pasteur-00819560</idno>
<idno type="halUri">https://hal-riip.archives-ouvertes.fr/pasteur-00819560</idno>
<idno type="halBibtex">kobinger:pasteur-00819560</idno>
<idno type="halRefHtml">Journal of Infectious Diseases, Oxford University Press (OUP), 2010, 201 (7), pp.1000-6. ⟨10.1086/651171⟩</idno>
<idno type="halRef">Journal of Infectious Diseases, Oxford University Press (OUP), 2010, 201 (7), pp.1000-6. ⟨10.1086/651171⟩</idno>
</publicationStmt>
<seriesStmt> <idno type="stamp" n="RIIP">Institut Pasteur RIIP (Réseau International)</idno>
<idno type="stamp" n="INRS-IAF" corresp="RIIP">Institut Armand Frappier</idno>
</seriesStmt>
<notesStmt> <note type="audience" n="2">International</note>
<note type="popular" n="0">No</note>
<note type="peer" n="1">Yes</note>
</notesStmt>
<sourceDesc> <biblStruct> <analytic> <title xml:lang="en">Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus.</title>
<author role="crp"> <persName> <forename type="first">Gary P</forename>
<surname>Kobinger</surname>
</persName>
<email type="md5">873e77335b5b1ffbd6dc15959e65d00c</email>
<email type="domain">phac-aspc.gc.ca</email>
<idno type="halauthorid">859639</idno>
<affiliation ref="#struct-224470"></affiliation>
<affiliation ref="#struct-224469"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Isabelle</forename>
<surname>Meunier</surname>
</persName>
<idno type="halauthorid">683563</idno>
<affiliation ref="#struct-54664"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Ami</forename>
<surname>Patel</surname>
</persName>
<idno type="halauthorid">846029</idno>
<affiliation ref="#struct-224469"></affiliation>
<affiliation ref="#struct-224470"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Stéphane</forename>
<surname>Pillet</surname>
</persName>
<idno type="halauthorid">752167</idno>
<affiliation ref="#struct-54664"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Jason</forename>
<surname>Gren</surname>
</persName>
<idno type="halauthorid">846030</idno>
<affiliation ref="#struct-224469"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Shane</forename>
<surname>Stebner</surname>
</persName>
<idno type="halauthorid">846031</idno>
<affiliation ref="#struct-224469"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Anders</forename>
<surname>Leung</surname>
</persName>
<idno type="halauthorid">846032</idno>
<affiliation ref="#struct-224469"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">James L</forename>
<surname>Neufeld</surname>
</persName>
<idno type="halauthorid">846033</idno>
<affiliation ref="#struct-224471"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Darwyn</forename>
<surname>Kobasa</surname>
</persName>
<idno type="halauthorid">752168</idno>
<affiliation ref="#struct-224469"></affiliation>
<affiliation ref="#struct-200544"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Veronika</forename>
<surname>Von Messling</surname>
</persName>
<idno type="halauthorid">752172</idno>
<affiliation ref="#struct-54664"></affiliation>
</author>
</analytic>
<monogr> <idno type="halJournalId" status="VALID">16582</idno>
<idno type="issn">0022-1899</idno>
<idno type="eissn">1537-6613</idno>
<title level="j">Journal of Infectious Diseases</title>
<imprint> <publisher>Oxford University Press (OUP)</publisher>
<biblScope unit="volume">201</biblScope>
<biblScope unit="issue">7</biblScope>
<biblScope unit="pp">1000-6</biblScope>
<date type="datePub">2010-04-01</date>
</imprint>
</monogr>
<idno type="doi">10.1086/651171</idno>
<idno type="pubmed">20170374</idno>
</biblStruct>
</sourceDesc>
<profileDesc> <langUsage> <language ident="en">English</language>
</langUsage>
<textClass> <classCode scheme="mesh">Animals</classCode>
<classCode scheme="mesh">Antibodies, Viral</classCode>
<classCode scheme="mesh">Interleukin-6</classCode>
<classCode scheme="mesh">Lung</classCode>
<classCode scheme="mesh">Nasal Cavity</classCode>
<classCode scheme="mesh">Orthomyxoviridae Infections</classCode>
<classCode scheme="mesh">Polymerase Chain Reaction</classCode>
<classCode scheme="mesh">RNA, Messenger</classCode>
<classCode scheme="mesh">Viral Load</classCode>
<classCode scheme="mesh">Body Temperature</classCode>
<classCode scheme="mesh">Body Weight</classCode>
<classCode scheme="mesh">Cytokines</classCode>
<classCode scheme="mesh">Disease Models, Animal</classCode>
<classCode scheme="mesh">Ferrets</classCode>
<classCode scheme="mesh">Hemagglutination</classCode>
<classCode scheme="mesh">Influenza A Virus, H1N1 Subtype</classCode>
<classCode scheme="mesh">Influenza Vaccines</classCode>
<classCode scheme="halDomain" n="sdv.mhep.mi">Life Sciences [q-bio]/Human health and pathology/Infectious diseases</classCode>
<classCode scheme="halTypology" n="ART">Journal articles</classCode>
</textClass>
<abstract xml:lang="en"> <p>BACKGROUND: The emergence and global spread of the pandemic H1N1 2009 influenza virus have raised questions regarding the protective effect of available seasonal vaccines and the efficacy of a newly produced matched vaccine. METHODS: Ferrets were immunized with the 2008-2009 formulations of commercially available live attenuated (FluMist; MedImmune) or split-inactivated (Fluviral; GlaxoSmithKline) vaccines, a commercial swine vaccine (FluSure; Pfizer), or a laboratory-produced matched inactivated whole-virus vaccine (A/Mexico/InDRE4487/2009). Adaptive immune responses were monitored, and the animals were challenged with A/Mexico/InDRE4487/2009 after 5 weeks. RESULTS: Only animals that received the swine or matched vaccines developed detectable hemagglutination-inhibiting antibodies against the challenge virus, whereas a T cell response was exclusively detected in animals vaccinated with FluMist. After challenge, all animals had high levels of virus replication in the upper respiratory tract. However, preexisting anti-pandemic H1N1 2009 antibodies resulted in reduced clinical signs and improved survival. Surprisingly, FluMist was associated with a slight increase in mortality and greater lung damage, which correlated with early up-regulation of interleukin-10. CONCLUSIONS: The present study demonstrates that a single dose of matched inactivated vaccine confers partial protection against a pandemic H1N1 2009 virus, and it suggests that a higher dose or prime-boost regimen may be required. The consequences of mismatched immunity to influenza merit further investigation.</p>
</abstract>
</profileDesc>
</hal>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Hal/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000066 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Hal/Curation/biblio.hfd -nk 000066 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= PandemieGrippaleV1 |flux= Hal |étape= Curation |type= RBID |clé= Hal:pasteur-00819560 |texte= Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus. }}
![]() | This area was generated with Dilib version V0.6.34. | ![]() |